Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 2 |
2003 | 2 |
2005 | 1 |
2006 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial.
Lancet Diabetes Endocrinol. 2020 Apr;8(4):301-312. doi: 10.1016/S2213-8587(20)30026-7. Epub 2020 Mar 2.
Lancet Diabetes Endocrinol. 2020.
PMID: 32135136
Clinical Trial.
Beneficial impact of spironolactone in diabetic nephropathy.
Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Rossing P, Tarnow L, Parving HH.
Schjoedt KJ, et al. Among authors: juhl tr.
Kidney Int. 2005 Dec;68(6):2829-36. doi: 10.1111/j.1523-1755.2005.00756.x.
Kidney Int. 2005.
PMID: 16316360
Free article.
Clinical Trial.
Item in Clipboard
Optimal dose of losartan for renoprotection in diabetic nephropathy.
Andersen S, Rossing P, Juhl TR, Deinum J, Parving HH.
Andersen S, et al. Among authors: juhl tr.
Nephrol Dial Transplant. 2002 Aug;17(8):1413-8. doi: 10.1093/ndt/17.8.1413.
Nephrol Dial Transplant. 2002.
PMID: 12147788
Item in Clipboard
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy.
Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Tarnow L, Rossing P, Parving HH.
Schjoedt KJ, et al. Among authors: juhl tr.
Kidney Int. 2006 Aug;70(3):536-42. doi: 10.1038/sj.ki.5001580. Epub 2006 Jun 14.
Kidney Int. 2006.
PMID: 16775595
Free article.
Clinical Trial.
Item in Clipboard
Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?
Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.
Andersen S, et al. Among authors: juhl tr.
Diabetes Care. 2003 May;26(5):1501-6. doi: 10.2337/diacare.26.5.1501.
Diabetes Care. 2003.
PMID: 12716812
Item in Clipboard
Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy.
Andersen S, Jacobsen P, Tarnow L, Rossing P, Juhl TR, Parving HH.
Andersen S, et al. Among authors: juhl tr.
Nephrol Dial Transplant. 2003 Feb;18(2):293-7. doi: 10.1093/ndt/18.2.293.
Nephrol Dial Transplant. 2003.
PMID: 12543883
Item in Clipboard
Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?
Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.
Andersen S, et al. Among authors: juhl tr.
Kidney Int. 2002 Jul;62(1):192-8. doi: 10.1046/j.1523-1755.2002.00410.x.
Kidney Int. 2002.
PMID: 12081578
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite